| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |